Study protocol of the fire-8 (aio-krk/ymo-0519) trial: a prospective, randomized, open-label, multicenter phase ii trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer

HIGHLIGHTS

• who: G. Sommerhu00e4user from the Department of Hematology, Oncology, and Cancer Immunology (CVK/ Universitu00e4t Berlin and Humboldt-Universitu00e4t zu Berlin, Berlin, Germany have published the article: Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer, in the Journal: (JOURNAL) of October/22,/2019
• what: The aim is to Department of Hematology Oncology and Immunology (CVK/ CCM) Charitu00e9 - Universitu00e4tsmedizin Berlin corporate member . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.